Key result
Angptl2 deficiency in a mouse model decreased abdominal aortic aneurysm development, reducing aneurysmal size and expression of proinflammatory cytokines and matrix metalloproteinase-9.
Why the study?
Does Angptl2 deficiency prevent abdominal aortic aneurysm development in a CaCl2-induced mouse model?
Does Angptl2 deficiency prevent abdominal aortic aneurysm development in a CaCl2-induced mouse model?
Answers are grounded in this paper and cite their sources.
Macrophage-derived Angptl2 promotes abdominal aortic aneurysm development via inflammation and extracellular matrix degradation, highlighting a potential novel therapeutic target.
OBJECTIVE: Recently, we reported that angiopoietin-like protein 2 (Angptl2) functions in various chronic inflammatory diseases. In the present study, we asked whether Angptl2 and its associated chronic inflammation contribute to abdominal aortic aneurysm (AAA). METHODS AND RESULTS: Immunohistochemistry revealed that Angptl2 is abundantly expressed in infiltrating macrophages within the vessel wall of patients with AAA and in a CaCl(2)-induced AAA mouse model. When Angptl2-deficient mice were used in the mouse model, they showed decreased AAA development compared with wild-type mice, as evidenced by reduction in aneurysmal size, less severe destruction of vessel structure, and lower expression of proinflammatory cytokines and matrix metalloproteinase-9. However, no difference in the number of infiltrating macrophages within the aortic aneurysmal vessel wall was observed between genotypes. AAA development was also significantly suppressed in wild-type mice that underwent Angptl2-deficient bone marrow transplantation. Expression levels of proinflammatory cytokines and metalloproteinase-9 in Angptl2-deficient macrophages were significantly decreased, and those decreases were rescued by treatment of Angptl2 deficient macrophages with exogenous Angptl2. CONCLUSIONS: Macrophage-derived Angptl2 contributes to AAA development by inducing inflammation and degradation of extracellular matrix in the vessel wall, suggesting that targeting the Angptl2-induced inflammatory axis in macrophages could represent a new strategy for AAA therapy.
No takes yet. Share an insight, caveat, or question.
Tazume et al. (2012) studied Abdominal aortic aneurysm. Angptl2 deficiency vs. Wild-type was evaluated on AAA development. Angptl2 deficiency in a mouse model decreased abdominal aortic aneurysm development, reducing aneurysmal size and expression of proinflammatory cytokines and matrix metalloproteinase-9.
Synapse has enriched 10 related papers. Consider them for comparative context: